The invention relates to a bone-conduction hearing
implant (100) comprising a subcutaneous implantable module (110) comprising a permanent
magnet (111), a first near-field
electromagnetic induction antenna (112), and a first
transducer (113). In one particular embodiment, the module has a magnetized one-piece body. The permanent
magnet (111) and the first
transducer (113) define, respectively, a first surface SDC1 of contact and a second surface SDC2 of contact with the
temporal bone OT. The module is positioned in a subperiosteal space ESP, the natural tension of the
periosteum maintaining the elements without invasive anchoring. The
implant interacts with a sound processor (200) and a
microphone, both of which are configurable externally or internally. There are two
modes of operation: internal transduction via the first
transducer (113) using bone-conduction
ultrasound technology and SDC2, and external transduction via the permanent
magnet (111) and SDC1. A detection
system (114) monitors the first transducer and ensures automatic switching. This non-invasive approach provides a scalable solution for different types of
hearing loss.